Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods

C. Oakman, L. Tenori, W. M. Claudino, S. Cappadona, S. Nepi, A. Battaglia, P. Bernini, E. Zafarana, E. Saccenti, M. Fornier, P. G. Morris, L. Biganzoli, C. Luchinat, I. Bertini, A. Di Leo
  • Annals of Oncology, January 2011, Oxford University Press (OUP)
  • DOI: 10.1093/annonc/mdq606

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Edoardo Saccenti